Table 1.
Participating Centers, Number of SOT Recipients per Center, and Virus Diagnostics Available at Each Center
| Hospital | No. of Patients | Viruses Tested by PCRa | Location and Type of Testing |
|---|---|---|---|
| Children’s Hospital of Philadelphia | 141 | hMPV, influenza, PIV, RSV, rhinovirus | In-house PCR assay |
| Children’s Hospital of Pittsburgh | 193 | hMPV, influenza, PIV, RSV, rhinovirus | In-house PCR assay |
| Cincinnati Children’s Medical Center | 165 | hMPV, influenza, PIV, RSV, rhinovirus | In-house PCR assay |
| Duke Children’s Hospitalb | 87 | hMPV, influenza, PIV, RSV | In-house PCR assay |
| Montefiore Children’s Hospital | 24 | hMPV, influenza, PIV, RSV, rhinovirus | In-house PCR assay |
| Seattle Children’s Hospital | 165 | hMPV, influenza, PIV, RSV, rhinovirus, coronavirus | In-house PCR assay at University of Washington (2010–2011); added FilmArray in 2012 |
| Texas Children’s Hospital | 256 | hMPV, influenza, PIV, RSV, rhinovirus, coronavirus | Combination of in-house PCR and commercial laboratory multiplex PCR assay |
| Monroe Carell Jr. Children’s Hospital at Vanderbilt | 65 | hMPV, influenza, PIV, RSV, rhinovirus, coronavirus | In-house PCR assay |
Abbreviations: hMPV, human metapneumovirus; PCR, polymerase chain reaction; PIV, parainfluenza virus; RSV, respiratory syncytial virus; SOT, solid organ transplant.
aIncludes viruses for which sites had PCR diagnostic testing available for clinical use during the entire study period.
bDuke Children’s Hospital performed rhinovirus culture but not PCR testing during the study period.